ClinicalTrials.gg
CompletedNCT07763288BANMOPUpdated Aug 13, 2026

Prevalence of Glaucoma and Normative Data of Ocular Biometry in Elderly Population in Bangkok

An observational study in Glaucoma, Glaucoma, Open-Angle and Glaucoma, Suspect, sponsored by Siriraj Hospital. Completed at 1 site in Thailand. Open to participants aged 50 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-13.

Sponsored by Siriraj Hospital · Observational

Study type
Observational
Model
Ecologic or community
Time perspective
Cross-sectional
Enrollment
1,470
Ages
50 Years and older
Sex
All
01

Study summary

The BANMOP eye study is an ophthalmic subproject of the Bangkoknoi Model Project (BANMOP), a community-based initiative integrating electronic health databases with population surveys to sup-port context-specific health promotion and prevention strategies. A total of 1,470 participants aged ≥50 years were recruited from community clusters in the Bangkoknoi district between April and Au-gust 2024. All participants underwent standardized ophthalmic examinations including slit-lamp bio-microscopy, noncontact tonometry (NCT), fundus photography, anterior segment optical coherence tomography (AS-OCT), and spectral-domain OCT (Spectralis, glaucoma module premium edition). Individuals suspected of glaucoma based on optic nerve head findings, intraocular pressure, or screen-ing results were referred for comprehensive evaluation by glaucoma specialists for definitive diagno-sis and classification.

Read the detailed description

Study Design and Population The Bangkoknoi Model Eye Project is a population-based cohort study conducted in 42 communities within the Bangkoknoi district, a suburban area of Bangkok, Thailand. Ethical approval was obtained from the Institutional Review Board of the Siriraj Hospital Faculty of Medicine, Mahidol University (COA No. SI 077/2024) according to the principles of the Declaration of Helsinki. The study was prospectively registered to Thai Clinical trial registration on July 19, 2023.

The project was partially funded by the National Health Security Office (NHSO), the Siriraj Social Responsibility Fund, and the Siriraj Research Development Fund (grant number R016733016), Siriraj Hospital Faculty of Medicine, Mahidol University.

The BANMOP community network management team, consisting of researchers and local coordinators, organized meetings with community leaders to facilitate the implementation of the study. The study was communicated through community leaders and the Bangkoknoi District Bureau to encourage voluntary participation. Using a convenience sampling approach, people aged ≥50 years from the 42 communities were invited to participate.

All examinations were performed using a mobile ophthalmic survey unit established at each community site, including community centers and schools, between April and August 2024.

Medical and Ocular History Participants were interviewed to obtain medical and ocular history, including previous eye diseases, ocular trauma, previous or current ophthalmic treatments or surgeries, and systemic comorbidities such as diabetes mellitus, hypertension, and dyslipidemia.

Uncorrected visual acuity (UCVA) and best-corrected visual acuity (BCVA) were measured using standardized protocols. Automated refraction was performed using an autorefractometer (AR-610; Nidek Co., Ltd., Tokyo, Japan). Blindness was defined as a BCVA worse than logMAR 1.3 (Snellen equivalent \<3/60).

Intraocular Pressure and Posterior Segment Imaging Intraocular pressure (IOP) was measured by experienced technicians using a noncontact pneumotonometer (CT-60 computerized tonometer; Topcon Ltd., Tokyo, Japan). At least three measurements were obtained for each eye and the mean value was used for analysis.

Color fundus photographs of the macula and optic disc were obtained using a fundus camera (CR6-45NM; Canon Inc., Tokyo, Japan). Spectral-domain optical coherence tomography (SD-OCT; Heidelberg Engineering, Germany) was performed to image the optic nerve head and macula using standard acquisition protocols. Because additional examinations, including Goldmann applanation tonometry (GAT), glaucoma module premium edition OCT (GMPE), and dark-room anterior segment OCT (AS-OCT), were not feasible for all participants within the constraints of a community-based mobile survey, these investigations were performed in a subset of participants using a convenience sampling approach. Comprehensive slit-lamp biomicroscopy was performed by ophthalmologists. Goldmann applanation tonometry (GAT) was performed by glaucoma specialists in the selected subset of participants.

Anterior Segment Assessment The depth of the anterior chamber was initially assessed using the van Herick method. Eyes with a peripheral anterior chamber depth less than one-quarter of the corneal thickness underwent gonioscopy, performed by experienced ophthalmologists using a 4-mirror goniolens. Anterior segment optical coherence tomography (AS-OCT) was performed under standard room lighting conditions to evaluate anterior chamber angle parameters, anterior chamber depth (ACD), central corneal thickness (CCT) and lens thickness (LT). Dark-room AS-OCT imaging was also performed in a subset of participants selected using convenience sampling.

Glaucoma Definition and Classification Glaucoma suspects were defined as individuals with suspicious glaucomatous features of the optic nerve head, including a cup-to-disc ratio >0.6, inter-eye asymmetry >0.2, localized neuroretinal rim loss, defects of the retinal nerve fiber layer, and/or IOP >21 mmHg (confirmed by GAT) with or without the corresponding SD-OCT abnormalities. All suspected glaucoma patients were referred to Siriraj Hospital for further evaluation, including Humphrey visual field (HVF) testing (SITA 24-2) and comprehensive examination by glaucoma specialists for definitive diagnosis. Glaucoma was defined by the presence of glaucomatous optic neuropathy (structural evidence) with corresponding glaucomatous defects of the visual field (functional evidence), and/or elevated IOP >21 mmHg measured by GAT. Glaucoma was classified as primary open-angle glaucoma (POAG), normal tension glaucoma (NTG), primary angle-closure glaucoma (PACG) and secondary glaucoma. Gonioscopy was performed in all cases of glaucoma, suspected glaucoma, and cases with angle-closure using the modified Shaffer grading system. Open angle glaucoma was defined by an open anterior chamber angle on gonioscopy.

Normal-tension glaucoma (NTG) was defined as glaucomatous optic neuropathy in eyes with open angles and untreated IOP \<21 mmHg. Ocular hypertension (OHT) was defined as IOP >21 mmHg without structural or functional glaucomatous damage.

Primary angle-closure disease (PACD) was defined as an occludable or closed anterior chamber angle, characterized by invisibility of ≥180° of the posterior trabecular meshwork on gonioscopy. PACD was further classified into primary angle-closure suspect (PACS), primary angle closure (PAC), and primary angle-closure glaucoma (PACG).

Secondary glaucoma was defined as glaucoma with an identifiable underlying cause. Pre-existing glaucoma cases were confirmed based on current glaucoma medications or review of medical records at Siriraj Hospital.

Statistical analysis was performed using SPSS for Windows, version 29.0 (SPSS Inc., Chicago, Illinois, USA). Continuous variables were summarized as mean ± standard deviation (SD), while categorical variables were presented as frequencies and percentages. Comparisons of proportions between groups were performed using the chi-square test or Fisher's exact test, as appropriate. Logistic regression models were used to evaluate associations between the presence of glaucoma and potential risk factors, including continuous variables (e.g., intraocular pressure) and categorical variables (e.g., unilateral blindness). The agreement between continuous variables were compared using intraclass correlation coefficient. All P values are 2-sided, and statistical significance was defined as P \< 0.05.

02

Conditions studied

  • Glaucoma
  • Glaucoma, Open-Angle
  • Glaucoma, Suspect
  • Glaucoma, Angle-Closure
  • Cataract
  • Blind Eye

Keywords

  • Glaucoma
  • prevalence,
  • epidemiological study
  • primary angle-closure
  • primary open angle glaucoma
  • optical coherence tomography
  • Asian
  • thailand
03

In context

Glaucoma

1,419 studies on the registry are indexed under Glaucoma; 223 are open to participants now.

This study's enrollment of 1,470 is above the median of 101 across 385 observational studies indexed under Glaucoma.

Browse Glaucoma studies →

Lead sponsor

Siriraj Hospital is the lead sponsor of 95 studies on the registry; 32 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The Bangkoknoi Model Eye Project is a population-based cohort study conducted in 42 communities within the Bangkoknoi district, a suburban area of Bangkok, Thailand. Using a convenience sampling approach, people aged ≥50 years from the 42 communities were invited to participate.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • people aged ≥50 years from the 42 communities of Bangkoknoi district of Bangkok

Exclusion criteria

Exclusion Criteria:

  • Individual who is unable to visit the mobile unit for eye examination.
05

Study design

Observational model
Ecologic or community
Time perspective
Cross-sectional
Enrollment
1,470 participants (actual)
Target follow-up
1 Year
Patient registry
Yes
06

What researchers measure

Primary outcomes

  1. the prevalence of glaucoma and its subtypes

    the prevalence of glaucoma and its subtypes in individuals 50 years of age and older including primary angle-closure diseases, primary open angle glaucoma, glaucoma suspect

    Time frame: 5 months between April 1st to August 31st, 2024

  2. characterize the spectrum of primary angle-closure diseases (PACD)

    characterize the spectrum of PACD according to ISGEO definitions, identify eyes at high risk of angle-closure disease

    Time frame: 5 months between April 1st to August 31st, 2024

Secondary outcomes

  1. Establish baseline ocular biometric and optical coherence tomography (OCT)-derived parameters in this population.

    establish baseline ocular biometric and OCT-derived parameters in this population including Spectral-domain optical coherence tomography (SD-OCT; Heidelberg Engineering, Germany) to image the optic nerve head and macula using standard acquisition protocols. Because additional examinations, including Goldmann applanation tonometry (GAT), glaucoma module premium edition OCT (GMPE), and dark-room anterior segment OCT (AS-OCT)

    Time frame: 5 months between April 1st to August 31st, 2024

07

Study locations

1 site
  • Naris Kitnarong
    Nonthaburi, 11000, Thailand
08

References and documents

Publications

  • Kitnarong N, Muangpaisan W, Kaweewongprasert P, Luerithiphong S, Apinuntavech S, Manaboriboon B, Talungchit P, Chainuvati S, Srinonprasert V, Kade S, Supamanee K, Assantachai P, Watanapa P. Electronic health databases and surveys for community-specific health promotion, prevention, and interventions: the Bangkoknoi Model Project (BANMOP). BMC Health Serv Res. 2025 May 10;25(1):678. doi: 10.1186/s12913-025-12837-z. PubMed 40349067 ↗
  • Foster PJ, Buhrmann R, Quigley HA, Johnson GJ. The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol. 2002 Feb;86(2):238-42. doi: 10.1136/bjo.86.2.238. PubMed 11815354 ↗
  • Bourne RR, Sukudom P, Foster PJ, Tantisevi V, Jitapunkul S, Lee PS, Johnson GJ, Rojanapongpun P. Prevalence of glaucoma in Thailand: a population based survey in Rom Klao District, Bangkok. Br J Ophthalmol. 2003 Sep;87(9):1069-74. doi: 10.1136/bjo.87.9.1069. PubMed 12928267 ↗
  • Yamamoto T, Iwase A, Araie M, Suzuki Y, Abe H, Shirato S, Kuwayama Y, Mishima HK, Shimizu H, Tomita G, Inoue Y, Kitazawa Y; Tajimi Study Group, Japan Glaucoma Society. The Tajimi Study report 2: prevalence of primary angle closure and secondary glaucoma in a Japanese population. Ophthalmology. 2005 Oct;112(10):1661-9. doi: 10.1016/j.ophtha.2005.05.012. PubMed 16111758 ↗
  • Foster PJ, Oen FT, Machin D, Ng TP, Devereux JG, Johnson GJ, Khaw PT, Seah SK. The prevalence of glaucoma in Chinese residents of Singapore: a cross-sectional population survey of the Tanjong Pagar district. Arch Ophthalmol. 2000 Aug;118(8):1105-11. doi: 10.1001/archopht.118.8.1105. PubMed 10922206 ↗

Individual participant data

Plan to share: Undecided — We did collect individual data of AS OCT, OCT of the disc and macula, demographic data which could be shared in reasonable purposes.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07763288
Lead sponsor
Siriraj Hospital
Responsible party
Naris Kitnarong (Associate professor, Siriraj Hospital) — Principal investigator
First posted
Aug 13, 2026
Start date
Apr 1, 2024
Primary completion
Aug 31, 2024
Completion
Jan 29, 2025
Last update
Aug 13, 2026

Study contacts

Naris Kitnarong
principal investigator · Mahidol University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion